SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-027784
Filing Date
2022-08-03
Accepted
2022-08-03 16:31:15
Documents
76
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q adpt-10q_20220630.htm   iXBRL 10-Q 2991978
2 EX-31.1 adpt-ex311_7.htm EX-31.1 30315
3 EX-31.2 adpt-ex312_10.htm EX-31.2 30549
4 EX-32.1 adpt-ex321_6.htm EX-32.1 12138
5 EX-32.2 adpt-ex322_9.htm EX-32.2 13407
  Complete submission text file 0001564590-22-027784.txt   9664794

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA adpt-20220630.xsd EX-101.SCH 56726
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE adpt-20220630_cal.xml EX-101.CAL 52302
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE adpt-20220630_def.xml EX-101.DEF 170245
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE adpt-20220630_lab.xml EX-101.LAB 415957
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adpt-20220630_pre.xml EX-101.PRE 332084
70 EXTRACTED XBRL INSTANCE DOCUMENT adpt-10q_20220630_htm.xml XML 1904581
Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

IRS No.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38957 | Film No.: 221133128
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences